Arteris, Inc. (NASDAQ:AIP – Get Free Report) major shareholder Bayview Legacy, Llc sold 2,756 shares of the stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $15.03, for a total transaction of $41,422.68. Following the sale, the insider owned 9,349,071 shares of the company’s stock, valued at $140,516,537.13. This trade represents a 0.03% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.
Bayview Legacy, Llc also recently made the following trade(s):
- On Monday, February 9th, Bayview Legacy, Llc sold 47,244 shares of Arteris stock. The shares were sold at an average price of $15.21, for a total value of $718,581.24.
- On Thursday, January 15th, Bayview Legacy, Llc sold 17,884 shares of Arteris stock. The stock was sold at an average price of $17.84, for a total transaction of $319,050.56.
- On Tuesday, January 13th, Bayview Legacy, Llc sold 2,116 shares of Arteris stock. The shares were sold at an average price of $17.79, for a total value of $37,643.64.
- On Thursday, January 8th, Bayview Legacy, Llc sold 50,000 shares of Arteris stock. The stock was sold at an average price of $16.58, for a total transaction of $829,000.00.
- On Monday, December 8th, Bayview Legacy, Llc sold 70,000 shares of Arteris stock. The shares were sold at an average price of $17.71, for a total transaction of $1,239,700.00.
- On Friday, December 5th, Bayview Legacy, Llc sold 60,000 shares of Arteris stock. The shares were sold at an average price of $17.08, for a total value of $1,024,800.00.
- On Thursday, December 4th, Bayview Legacy, Llc sold 40,000 shares of Arteris stock. The stock was sold at an average price of $16.46, for a total transaction of $658,400.00.
Arteris Stock Performance
Arteris stock traded up $0.01 during midday trading on Wednesday, reaching $15.10. The stock had a trading volume of 411,831 shares, compared to its average volume of 427,672. The firm’s fifty day simple moving average is $16.32 and its 200-day simple moving average is $13.22. The stock has a market capitalization of $659.57 million, a P/E ratio of -18.19 and a beta of 1.47. Arteris, Inc. has a 1-year low of $5.46 and a 1-year high of $19.85.
Wall Street Analyst Weigh In
View Our Latest Research Report on Arteris
Arteris News Summary
Here are the key news stories impacting Arteris this week:
- Positive Sentiment: NXP Semiconductors expanded its deployment of Arteris system IP (FlexNoC, Ncore, CodaCache) and integration tools across AI-enabled SoC, NPU and MCU designs — a clear commercial validation that can drive revenue growth and visibility in edge AI markets. Arteris Technology Deployed More Broadly by NXP
- Positive Sentiment: Institutional buying and analyst coverage remain constructive: multiple funds added AIP in recent quarters and Rosenblatt has a Buy rating (recent median price target ~$18.25), supporting upside vs. current levels.
- Neutral Sentiment: Q4 2025 earnings preview published — upcoming results could move the stock, but the preview itself contains no surprise guidance. Monitor the actual earnings release for revenue/visibility vs. AI-related design wins. What to Expect from Arteris Inc (AIP) Q4 2025 Earnings
- Neutral Sentiment: Short-interest reporting in the recent feeds is inconsistent (entries showing 0 shares or NaN alongside earlier data showing ~1.13M shares shorted as of Jan 30). Data appears noisy — treat short‑interest signals cautiously until exchanges/registrars reconcile the figures.
- Negative Sentiment: Insiders sold stock this week: CEO K. Charles Janac sold 47,244 shares on Feb 9 (~$15.21 avg) and 2,756 shares on Feb 10 (~$15.03 avg); major shareholder Bayview Legacy, LLC reported the same sales. The activity adds to a pattern of frequent insider sales reported over recent months and could weigh on sentiment. SEC filing: Janac insider sales
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in AIP. AQR Capital Management LLC acquired a new position in Arteris during the first quarter worth $1,621,000. Strs Ohio purchased a new stake in shares of Arteris during the first quarter valued at approximately $104,000. Acuitas Investments LLC purchased a new stake in shares of Arteris during the 2nd quarter valued at $858,000. AlphaQuest LLC raised its position in Arteris by 65.1% in the second quarter. AlphaQuest LLC now owns 64,504 shares of the company’s stock worth $615,000 after acquiring an additional 25,426 shares during the period. Finally, Savant Capital LLC bought a new stake in shares of Arteris in the 2nd quarter worth approximately $97,000. 64.36% of the stock is owned by institutional investors and hedge funds.
About Arteris
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Further Reading
- Five stocks we like better than Arteris
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
